Literature DB >> 1713254

CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).

H E Broxmeyer1, L Lu, G Hangoc, S Cooper, P C Hendrie, J A Ledbetter, M Xiao, D E Williams, F W Shen.   

Abstract

CD45 antigens are protein tyrosine phosphatases. A possible link was evaluated between expression of CD45 antigens on human myeloid progenitor cells (MPC) (colony-forming unit-granulocyte/macrophage [CFU-GM], burst-forming unit-erythroid [BFU-E], and colony-forming unit-granulocyte/erythroid/macrophage/megakaryocyte [CFU-GEMM]) and regulation of MPC by colony-stimulating factors (CSF) (interleukin 3 [IL-3], GM-CSF, G-CSF, M-CSF, and erythropoietin [Epo]), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (MGF; a c-kit ligand). Treatment of cells with antisense oligodeoxynucleotides (oligos) to exons 1 and 2, but not 4, 5, or 6, of the CD45 gene, or with monoclonal anti-CD45, significantly decreased CFU-GM colony formation stimulated with GM-CSF, IL-3, fusion protein, and GM-CSF + MGF, but not with G-CSF or M-CSF. It also decreased GM-CSF, IL-3, fusion protein, and MGF-enhanced Epo-dependent BFU-E and CFU-GEMM colony formation, but had little or no effect on BFU-E or CFU-GEMM colony formation stimulated by Epo alone. Similar results were obtained with unseparated or purified (greater than or equal to one of two cells being a MPC) bone marrow cells. Sorted populations of CD343+ HLA-DR+ marrow cells composed of 90% MPC were used to demonstrate capping of CD45 after crosslinking protocols. Also, a decreased percent of CD45+ cells and CD45 antigen density was noted after treatment of column-separated CD34+ cells with antisense oligos to exon 1 of the CD45 gene. These results demonstrate that CD45 cell surface antigens are linked to stimulation of early human MPC by IL-3, GM-CSF, a GM-CSF/IL-3 fusion protein, and MGF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713254      PMCID: PMC2118912          DOI: 10.1084/jem.174.2.447

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

Authors:  E Huang; K Nocka; D R Beier; T Y Chu; J Buck; H W Lahm; D Wellner; P Leder; P Besmer
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

2.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  CD45 cross-linking regulates phospholipase C activation and tyrosine phosphorylation of specific substrates in CD3/Ti-stimulated T cells.

Authors:  J A Ledbetter; G L Schieven; F M Uckun; J B Imboden
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

4.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

Authors:  C H June; M C Fletcher; J A Ledbetter; G L Schieven; J N Siegel; A F Phillips; L E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

6.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

7.  Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma.

Authors:  R J Berenson; W I Bensinger; R S Hill; R G Andrews; J Garcia-Lopez; D F Kalamasz; B J Still; G Spitzer; C D Buckner; I D Bernstein
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

8.  Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.

Authors:  H E Broxmeyer; S Cooper; L Lu; G Hangoc; D Anderson; D Cosman; S D Lyman; D E Williams
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

9.  Influence of murine mast cell growth factor (c-kit ligand) on colony formation by mouse marrow hematopoietic progenitor cells.

Authors:  H E Broxmeyer; G Hangoc; S Cooper; D Anderson; D Cosman; S D Lyman; D E Williams
Journal:  Exp Hematol       Date:  1991-02       Impact factor: 3.084

10.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.

Authors:  S Nishibe; M I Wahl; S M Hernández-Sotomayor; N K Tonks; S G Rhee; G Carpenter
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  4 in total

1.  Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.

Authors:  David M Harris; Inbal Hazan-Haley; Kevin Coombes; Carlos Bueso-Ramos; Jie Liu; Zhiming Liu; Ping Li; Murali Ravoori; Lynne Abruzzo; Lin Han; Sheela Singh; Michael Sun; Vikas Kundra; Razelle Kurzrock; Zeev Estrov
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

2.  Hematopoietic colony formation from human growth factor-dependent TF1 cells and human cord blood myeloid progenitor cells depends on SHP2 phosphatase function.

Authors:  Hal E Broxmeyer; Maryse Etienne-Julan; Akihiko Gotoh; Stephen E Braun; Li Lu; Scott Cooper; Gen-Sheng Feng; Xing Jun Li; Rebecca J Chan
Journal:  Stem Cells Dev       Date:  2012-12-16       Impact factor: 3.272

3.  Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.

Authors:  P M Lansdorp; W Dragowska
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

4.  Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells.

Authors:  S A Berger; T W Mak; C J Paige
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.